These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23360883)

  • 21. The genetics of inflammatory bowel disease.
    Bonen DK; Cho JH
    Gastroenterology; 2003 Feb; 124(2):521-36. PubMed ID: 12557156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evidence for immunomodulatory effects of probiotic bacteria.
    Ruemmele FM; Bier D; Marteau P; Rechkemmer G; Bourdet-Sicard R; Walker WA; Goulet O
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):126-41. PubMed ID: 19179874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response.
    Thompson-Chagoyán OC; Maldonado J; Gil A
    Clin Nutr; 2005 Jun; 24(3):339-52. PubMed ID: 15896420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inflammatory bowel disease: genotype-fenotype relationship].
    Gómez de la Concha E
    An R Acad Nac Med (Madr); 2006; 123(2):307-17; discussion 318-20. PubMed ID: 17310638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host-bacteria interaction in inflammatory bowel disease.
    Knight P; Campbell BJ; Rhodes JM
    Br Med Bull; 2008; 88(1):95-113. PubMed ID: 18931057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased prevalence of pathogenic bacteria in the gut microbiota of infants at risk of developing celiac disease: The PROFICEL study.
    Olivares M; Benítez-Páez A; de Palma G; Capilla A; Nova E; Castillejo G; Varea V; Marcos A; Garrote JA; Polanco I; Donat E; Ribes-Koninckx C; Calvo C; Ortigosa L; Palau F; Sanz Y
    Gut Microbes; 2018 Nov; 9(6):551-558. PubMed ID: 29672211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota, probiotics and inflammatory bowel disease.
    Stephani J; Radulovic K; Niess JH
    Arch Immunol Ther Exp (Warsz); 2011 Jun; 59(3):161-77. PubMed ID: 21445715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DQ2 and -DQ8 genotypes in celiac and healthy Libyan children.
    Alarida K; Harown J; Di Pierro MR; Drago S; Catassi C
    Dig Liver Dis; 2010 Jun; 42(6):425-7. PubMed ID: 19819768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
    Bodd M; Kim CY; Lundin KE; Sollid LM
    Gastroenterology; 2012 Mar; 142(3):552-61. PubMed ID: 22108197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coeliac disease: dissecting a complex inflammatory disorder.
    Sollid LM
    Nat Rev Immunol; 2002 Sep; 2(9):647-55. PubMed ID: 12209133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory bowel disease.
    Boirivant M; Cossu A
    Oral Dis; 2012 Jan; 18(1):1-15. PubMed ID: 21564424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inflammatory bowel diseases: an immunological approach].
    Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteria in the pathogenesis of inflammatory bowel disease.
    Flanagan P; Campbell BJ; Rhodes JM
    Biochem Soc Trans; 2011 Aug; 39(4):1067-72. PubMed ID: 21787349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory bowel disease and celiac disease: overlaps in the pathology and genetics, and their potential drug targets.
    Festen EA; Szperl AM; Weersma RK; Wijmenga C; Wapenaar MC
    Endocr Metab Immune Disord Drug Targets; 2009 Jun; 9(2):199-218. PubMed ID: 19519468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles.
    Pietzak MM; Schofield TC; McGinniss MJ; Nakamura RM
    Clin Gastroenterol Hepatol; 2009 Sep; 7(9):966-71. PubMed ID: 19500688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The genetic basis of inflammatory bowel disease unravelled by genetic association studies].
    Visschedijk MC; Festen EA; Wijmenga C; Weersma RK
    Ned Tijdschr Geneeskd; 2009; 153():A402. PubMed ID: 19900309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Celiac disease: from pathogenesis to novel therapies.
    Schuppan D; Junker Y; Barisani D
    Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbiome and Gluten.
    Sanz Y
    Ann Nutr Metab; 2015; 67 Suppl 2():28-41. PubMed ID: 26605783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects.
    Megiorni F; Mora B; Bonamico M; Barbato M; Montuori M; Viola F; Trabace S; Mazzilli MC
    Am J Gastroenterol; 2008 Apr; 103(4):997-1003. PubMed ID: 18177450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.